Abbott Q2 2022 Earnings Report
Key Takeaways
Abbott announced strong second-quarter results, with worldwide sales increasing by 10.1 percent on a reported basis and 14.3 percent on an organic basis. The company is raising its full-year EPS guidance.
Total worldwide sales increased 10.1 percent on a reported basis and 14.3 percent on an organic basis.
Global COVID-19 testing-related sales were $2.3 billion in the quarter.
FreeStyle Libre sales were approximately $1.1 billion, representing sales growth of 18.7 percent on a reported basis and 25.6 percent on an organic basis.
Abbott is raising its projected full-year 2022 diluted earnings per share under GAAP to at least $3.50 and adjusted diluted earnings per share to at least $4.90.
Abbott
Abbott
Forward Guidance
Abbott is raising its projected full-year 2022 diluted earnings per share under GAAP to at least $3.50. Excluding specified items, Abbott is raising its projected adjusted diluted earnings per share to at least $4.90 for the full-year 2022.